Trilogy Capital’s Invesco BulletShares 2021 Corporate Bond ETF BSCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-246,989
Closed -$5.21M 176
2021
Q3
$5.21M Sell
246,989
-18,974
-7% -$400K 0.4% 46
2021
Q2
$5.61M Sell
265,963
-26,944
-9% -$569K 0.41% 46
2021
Q1
$6.19M Sell
292,907
-79,817
-21% -$1.69M 0.47% 44
2020
Q4
$7.91M Sell
372,724
-28,670
-7% -$610K 0.65% 43
2020
Q3
$8.56M Buy
401,394
+42,269
+12% +$903K 0.82% 38
2020
Q2
$7.68M Buy
359,125
+38,996
+12% +$831K 0.76% 41
2020
Q1
$6.77M Buy
320,129
+50,206
+19% +$1.06M 0.75% 40
2019
Q4
$5.74M Buy
269,923
+44,165
+20% +$939K 0.56% 48
2019
Q3
$4.81M Buy
225,758
+17,861
+9% +$379K 0.51% 50
2019
Q2
$4.4M Buy
207,897
+48,844
+31% +$1.03M 0.49% 47
2019
Q1
$3.35M Buy
159,053
+25,135
+19% +$525K 0.4% 54
2018
Q4
$2.78M Buy
133,918
+63,538
+90% +$1.31M 0.37% 44
2018
Q3
$1.46M Buy
70,380
+62,663
+812% +$1.3M 0.18% 40
2018
Q2
$160K Buy
+7,717
New +$160K 0.02% 140

Other funds holding BSCL

Trilogy Capital's BSCL Position: Q4 2021 in Review

Trilogy Capital sold out of Invesco BulletShares 2021 Corporate Bond ETF (BSCL) in Q4 2021, closing a stake of 246,989 shares — an estimated $5.21M sold.

Trilogy Capital first reported a position in BSCL in Q2 2018 and held it in 14 quarters. The position peaked at $8.56M in Q3 2020. 1 fund tracked by Wall St. Rank holds BSCL as of Q4 2021.

  • Trilogy Capital reported no remaining Invesco BulletShares 2021 Corporate Bond ETF position as of Q4 2021 after selling out during the quarter.
  • Trilogy Capital sold 246,989 Invesco BulletShares 2021 Corporate Bond ETF shares in Q4 2021, an estimated $5.21M.
  • Trilogy Capital first reported a position in Invesco BulletShares 2021 Corporate Bond ETF in Q2 2018 and held it in 14 quarters.
  • Trilogy Capital's Invesco BulletShares 2021 Corporate Bond ETF position peaked at $8.56M in Q3 2020.
  • 1 fund tracked by Wall St. Rank held Invesco BulletShares 2021 Corporate Bond ETF as of Q4 2021.

Based on Trilogy Capital's 13F filing for Q4 2021, filed 18 Jan 2022.